Deutsche Bank raised the firm’s price target on Novo Nordisk to DKK 850 from DKK 775 and keeps a Buy rating on the shares.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on NVO:
- Novo Nordisk reports COMBINE 3 phase 3a trial achieved primary endpoint
- Tiziana Life files new patent application related to GLP-1ra, foralumab
- Novo Nordisk call volume above normal and directionally bullish
- Omega (NASDAQ:OMGA) Skyrockets After Research Deal With Novo Nordisk
- Novo Nordisk enters research pacts with Omega Therapeutics, Cellarity